Advertisement
Advertisement
Enerzair Breezhaler

Enerzair Breezhaler Description

Manufacturer:

Novartis

Distributor:

Zuellig
Full Prescribing Info
Description
Capsules with green transparent cap and uncoloured transparent body containing a white powder, with the product code "IGM150-50-160" printed in black above two black bars on the body and with the product logo printed in black and surrounded by a black bar on the cap.
Each capsule contains 150 mcg of indacaterol (as acetate), 63 mcg of glycopyrronium bromide equivalent to 50 mcg of glycopyrronium and 160 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 114 mcg of indacaterol (as acetate), 58 mcg of glycopyrronium bromide equivalent to 46 mcg of glycopyrronium and 136 mcg of mometasone furoate.
Excipient(s) with known effect: Each capsule contains 25 mg of lactose monohydrate.
Excipients/Inactive Ingredients: Capsule contents: Lactose monohydrate, Magnesium stearate.
Capsule shell: Hypromellose, Printing ink.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement